Desalting and Buffer Exchange Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

The Desalting and Buffer Exchange market is segmented by Product (Cassettes and Cartridges, Kits, Filter Plates, and Others), By Technique (Filtration, Chromatography, and Precipitation), Application ( Diagnostic Application, Pharmaceutical and Biotechnology Industries, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Desalting And Buffer Exchange Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 10 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The desalting and buffer exchange market is projected to register a CAGR of 10% during the forecast period (2022-2027).

The sudden outbreak of COVID-19 and the rise in the number of COVID-19 infection cases across the world increased the demand for vaccination and drugs. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2021, 11 billion COVID- 19 vaccines will be produced, and nearly 200 vaccine candidates are in the production pipeline. The desalting and buffer exchange products have been extensively used in the vaccine production process as the buffer exchange is an important step in the downstream process. Hence, COVID-19 is expected to positively impact the desalting and buffer exchange market due to the increasing demand for effective COVID- 19 vaccination.

Increasing demand for biopharmaceutical products coupled with the rise in the research and development expenditure in biopharmaceutical products is expected to drive the market's growth. This is mainly due to the crucial role of the desalting and buffer exchange in the downstream production process of the drugs. According to the Global Use of Medicine in 2019 and Outlook to 2023, the global pharmaceutical market is expected to grow by over USD 1.5 trillion by 2023. The report published by the International Federation of Pharmaceutical Manufacturers and Association (IFPMA) in 2021, the biopharmaceutical research and expenditure in 2020 is over USD 189 billion globally. Therefore, the increasing expenditure on the research and development of biopharmaceuticals is expected to boost the market's growth as they use desalting and buffer exchange systems extensively in the manufacturing process.

Scope of the Report

As per the scope of this report, desalting occurs when buffer salts and other molecules are removed from a sample in exchange for water. Buffer exchange occurs when the buffer salts in a sample are exchanged for those in another buffer. The Desalting and Buffer Exchange market is segmented by Product (Cassettes and Cartridges, Kits, Filter Plates, and Others), By Technique (Filtration, Chromatography, and Precipitation), Application ( Bioprocess Application, Diagnostic Application, Pharmaceutical and Biotechnology Industries, and Others) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.

By Product
Cassettes and Catridges
Kits
Filter plates
Others
By Technique
Filtration
Chromatography
Precipitation
By Application
Pharmaceutical and Biotechnology Industries
Diagnostic Applications
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Pharmaceutical and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Desalting and Buffer Exchange Market.

During COVID-19, there is a rapid increase in market desalting and buffer exchange demand. This is mainly due to the increasing demand for biopharmaceutical drugs, effective therapies, and increasing research and development in the pharmaceutical and biotechnology industries during the pandemic era.

The increasing application of the desalting and buffer exchange systems in the Biopharmaceutical industries is expected to drive the market's growth. The desalting and buffer exchange systems also play a crucial role in the manufacture of the products. The increase in the research and developmental activities in biopharmaceutical industries in order to produce the products will increase the demand for desalting and buffer exchange systems. For instance, in 2020, the data published by Nature Journal states that 53 novel therapeutics are approved by Food and Drug Administration (FDA). Thus the increasing drug production reflects the demand for desalting and buffer exchange systems as the buffer exchange is an essential step in the downstream process. Also, key factors such as increasing expenditure in the research and development by biopharmaceutical industries to novel treatments are expected to significantly impact the market's growth. According to the data published by Organisation for Economic Co-Operation and Development (OECD) in 2020, the pharmaceutical industry spent nearly USD 101 Billion on Research and Development in the OECD countries. Also, the same source also reported that global R&D spending by the largest publicly traded companies grew 13.7% annually. Therefore, the increasing expenditure on the research and development by the biopharmaceutical and biotechnology industries to develop their product pipeline is expected to boost the growth of the desalting and buffer exchange market.

Desalting And Buffer Exchange Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The United States is anticipated to hold a major share in the desalting and buffer exchange market. Increasing demand for biopharmaceuticals and rising research and development expenditure for biopharmaceutical companies are the contributing factors to the market growth in this region. According to Organisation for Economic Co-operation and Development (OECD), in 2020, the United States recorded USD 0.61 Million in research and development expenditure in the biopharmaceutical industry. Thus the increasing research and development expenditure in the pharmaceutical industry is a major factor that propels the growth of the market in this region. Furthermore, the presence of the major market players in this region spending extensively on the research and development of new products is also expected to boost the growth of the market in this region. According to the data published by Organisation for Economic Co-Operation and Development (OECD) in 2020, the pharmaceutical industry spent nearly USD 101 Billion on Research and Development in the OECD countries. Also, the same source also reported that global R&D spending by the largest publicly traded companies grew 13.7% annually. Therefore, the increasing expenditure on the research and development by the biopharmaceutical and biotechnology industries to develop their product pipeline is expected to boost the growth of the desalting and buffer exchange market.

Desalting And Buffer Exchange Market Forecast

Competitive Landscape

The desalting and buffer exchange market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are ThremoFisher Scientific, Sartorius AG, Merck KGaA, Agilient Technologies Inc., Repligen, PhyNexus, Inc, Biogen, Norgen Biotec Corp., Danaher, and others

Recent Developments

In October 2021, Novasep launched the novel industrial-scale HPLC system called Hipersep process M for more secure and productive bioprocessing solutions.

In October 2021, Biotage, a Swedish drug discovery and analytics company acquired DNA synthesis and purification company ATDBio for approximately EUR 45 million.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definitions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Research and development by Biopharmaceutical industries

      2. 4.2.2 Rising focus on the Proteomic and Genomic Research

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled professional

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Cassettes and Catridges

      2. 5.1.2 Kits

      3. 5.1.3 Filter plates

      4. 5.1.4 Others

    2. 5.2 By Technique

      1. 5.2.1 Filtration

      2. 5.2.2 Chromatography

      3. 5.2.3 Precipitation

    3. 5.3 By Application

      1. 5.3.1 Pharmaceutical and Biotechnology Industries

      2. 5.3.2 Diagnostic Applications

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 ThermoFisher Scientific

      2. 6.1.2 Sartorius AG

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Agilient Technologies, Inc.

      5. 6.1.5 Repligen

      6. 6.1.6 PhyNexus Inc

      7. 6.1.7 Bioworks

      8. 6.1.8 Norgen Bioteck Corp

      9. 6.1.9 Danaher

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Desalting and Buffer Exchange Market market is studied from 2019 - 2027.

The Global Desalting and Buffer Exchange Market is growing at a CAGR of 10% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific, Sartorius AG, Merck KGaA, Agilient Technologies, Inc, Danaher are the major companies operating in Global Desalting and Buffer Exchange Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!